Allergan Aesthetics, an AbbVie Company · 2 days ago
Finance Director, Demand Planning Immunology
Mettawa, IL
Full-time
Onsite
Director/Executive
$156K/yr - $296K/yr
12+ years expAllergan Aesthetics, an AbbVie Company, is seeking a Finance Director for Demand Planning in Immunology. The role focuses on monitoring the stability of AbbVie products in the U.S. supply channel, ensuring equitable product allocation, and providing insights on purchase trends for Immunology brands.
BeautyManufacturingPharmaceuticalWellness
Responsibilities
Collaborate closely with various Immunology stakeholders in proactively identifying product trends, providing channel insights & linkage to multiple data sources
Communicate with external wholesale and major pharmacy customers to gain deeper insights on product purchase trends, inventory levels, dispensing -- through enhanced data analytics and present interpretation of business impact to AbbVie leadership
Ownership for implementing ongoing continuous improvement within span of control including data management and analytical modeling
Develop familiarity with all components of AbbVie’s Distribution Service Agreements, command of wholesaler contractual terms and situational business applications
Review actual DSA performance and metric achievement for compensation
Provide support to Senior Director, Demand Planning, in projecting “to-market” volumes to inform LBE’s through collaboration with Brand Forecasting and APEX
Leverage existing channel modeling tools and build/create adhoc analytics as business trends dictate, bringing proactive visibility to supply channel dynamics and drivers
Manage staff supporting Demand Planning Immunology in the execution of AbbVie’s Distribution Service Agreements and daily Immunology product activity in the supply channel
Ownership for staff supervision and development
Qualification
Required
Bachelor's or Master's degree in Finance or Accounting. Advanced degree a plus
Overall business experience to include commercial finance, cost accounting, auditing, financial reporting or financial planning and analysis is required
Experience in a complex global organization. Pharmaceutical sector experience a plus
12+ years of progressive Accounting or Finance with 5+ years of management experience
Strong Microsoft Excel & PowerPoint skills, SAP, scenario planning experience and data presentation skills/storytelling
Demonstrated project management skills and experience, which includes project leadership in organizing, planning and executing projects from vision through implementation
Strong analytical skills – able to synthesize data into concise information to make decisions, recommendations and proposals
Demonstrated ability working in a matrix organization, building strong partnerships, and accessing available resources
Flexible, adapt to changing priorities, demonstrate persistence in following through, and able to make timely decisions/recommendations based on data
High personal integrity, energy and objectivity
Process focused with experience in implementing process improvements or other change management initiatives
Ability for managing multiple priorities in a dynamic and challenging environment
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
Allergan Aesthetics, an AbbVie Company
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products.
1001-5000 employees
H1B Sponsorship
Allergan Aesthetics, an AbbVie Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2023 (1)
2022 (16)
2021 (14)
2020 (5)
Funding
Current Stage
Late StageLeadership Team
Nicole Mowad-Nassar
Senior Vice President, AbbVie and President, Global Allergan Aesthetics
Recent News
2025-12-04
Company data provided by crunchbase